A newly-conducted study has discovered that going to bed between 10pm and 11pm reduces the risk of developing heart disease.
If you ever needed an excuse for an early night, this is it.
The study – which was written by Dr David Plans of the University of Exeter, and published in European Heart Journal – Digital Health, a journal of the European Society of Cardiology (ESC) – found that compared to falling asleep between 10pm and 10.59pm, there was a 12% greater risk of developing cardiovascular diseases for 11pm to 11.59 pm, and a 24% increased risk for falling asleep before 10pm.
There was also a 25% higher risk of cardiovascular disease associated with falling asleep at midnight or later.
The study included 88,026 people in the UK Biobank study, recruited between 2006 and 2010, with the average age of study participants being 61 years.
ADVERTISEMENT
Participants were aged between 43 and 79 years old, with 58% women.
“The body has a 24-hour internal clock, called circadian rhythm, that helps regulate physical and mental functioning,” Dr David Plans explained.
ADVERTISEMENT
“While we cannot conclude causation from our study, the results suggest that early or late bedtimes may be more likely to disrupt the body clock, with adverse consequences for cardiovascular health.”
The study included 88,026 people in the UK Biobank study, recruited between 2006 and 2010 / Credit: Flickr
Not only that, but a further analysis by sex found that the increased cardiovascular risk was also stronger in women.
Before the study, participants were required to complete demographic, lifestyle, health, and, physical assessments and questionnaires, and then researchers collected data on sleep onset and waking up time over seven days using a device worn on the wrist.
ADVERTISEMENT
Participants were then followed up for a new diagnosis of cardiovascular disease – which was defined as a heart attack, heart failure, chronic ischaemic heart disease, stroke, and transient ischaemic attack – and during an average follow-up of 5.7 years, 3,172 participants (3.6%) developed cardiovascular disease, according to the study.
The study ultimately found that this diagnosis was the highest in those with bed times at midnight or later, and the lowest in those with sleep onset from 10pm to 10.59 pm.
Dr David Plans admitted that the reasons for the observed stronger association between sleep onset and cardiovascular disease in women is unclear, but concluded that: “While the findings do not show causality, sleep timing has emerged as a potential cardiac risk factor – independent of other risk factors and sleep characteristics.”
“It’s important to remember that this study can only show an association and can’t prove cause and effect,” added Regina Giblin – Senior Cardiac Nurse at the British Heart Foundation.
Featured Image – Pixabay
News
Manchester City win first Women’s Super League title in a decade
Danny Jones
After a decade of hope and hard work, Manchester City have finally won the Women’s Super League once again in a huge moment for the local club.
Lifting not just their first division title in 10 years, but only their second WSL trophy since the modern female football era began in 2010, it felt like only a matter of time to many supporters.
Ending a six-year Chelsea supremacy, this is also manager Andrée Jeglertz’s first at the helm of Man City’s women’s team, who arrived at the club with a strong silverware record at the start of this season.
These were the scenes at home base as one key result sealed their status as champions:
— Manchester City Women (@ManCityWomen) May 6, 2026
City Women secured the WSL title following third-placed Arsenal’s 1-1 draw against Brighton on Wednesday evening.
They even managed to do so with a game to spare and a six-point gap over the west London club, which has won so much over the past few years.
Speaking in an interview with club media after confirmation of the win, captain and Euro 2025 winner Alex Greenwood said: “[It feels] absolutely incredible. “A moment – we as a team, me personally – us as a club has waited so long for”.
“An incredible moment, it’s an incredible feeling. I’m so glad we got to spend this moment together as a group. Just an absolutely incredible feeling.”
With fans watching both at home, along with the first team themselves, the celebrations have already begun as the team shared a look back at how they got here.
You can see the recap posted on social media in full below.
Commenting on his latest accolade, the Swedish head coach added in a full club statement: “There’s never been doubt about the talent in the group, but there is something else about talking about being winners and champions. We started that early, and we believed in that. That’s led us through this year.
“It hasn’t been easy; it’s been hard work every day, but we had a strong belief that we could be sitting here in May and be champions. That is the first thing, and we definitely deserve it.”
Congratulations to the Cityzens on a well-deserved and long-awaited WSL title; could this be the start of another sporting dynasty of dominance over in East Manchester? Only time will tell…
In other news around the Etihad Campus, the women’s, EDS and academy team stadium is also set to host the final of the FA Youth Cup later this month.
Groundbreaking new ‘rapid’ jab to treat 14 different cancer types now available on NHS
Emily Sergeant
A groundbreaking new ‘rapid’ cancer jab that can be administered in just 60 seconds is now available on the NHS.
It’s hoped that tens of thousands of patients on the NHS could benefit from the new immunotherapy jab – which is an injectable form of pembrolizumab (Keytruda) – as it can slash the time the treatment takes by up to 90%, helping people spend less time in hospital while also improving the health service’s productivity.
The jab can be used to treat 14 different types of cancer, including lung, breast, head and neck, and cervical cancers.
Put simply, it works by triggering immune cells to recognise and kill cancer cells.
The new under-the-skin injection replaces an intravenous (IV) infusion – which can take up to two hours in total, per session – sparing patients ‘unnecessary’ time in treatment units and freeing up capacity for clinicians to see and treat more people.
Tens of thousands of patients could benefit from a 'rapid' immunotherapy jab for over a dozen cancers.
Given in just minutes, the new jab will cut treatment time, help patients spend less time in hospital – and boost NHS productivity.
The treatment will be given every three weeks as a one-minute injection, or every six weeks as a two-minute injection, depending on an individual’s cancer type.
Currently, around 14,000 patients start pembrolizumab therapy each year in England, and most are now expected to benefit from this more-convenient treatment.
Speaking on the rollout of the new jab this week, Professor Peter Johnson, who is the NHS National Clinical Director for Cancer, said: “This immunotherapy offers a lifeline for thousands of patients and it’s fantastic that this new rapid jab can now take just a minute to deliver, meaning patients can get back to living their lives rather than spending hours in a hospital chair.
“Managing cancer treatment and regular hospital trips can be really exhausting.
“Not only will this innovation make therapy much quicker and more convenient for patients, it will also help free up vital appointments for NHS teams to treat more people and continue to bring down waiting times”.